Skip to main content

Telix Pharmaceuticals Health Care

$11.22 -0.22 (-1.92%)

High

$11.49

Low

$11.20

Trades

4,718

Turnover

$7,499,551

Volume

664,557
30 June 2023 at 4:12pm
Register to track TLX and receive email alerts.
TLX Announcements on Price Chart

Latest Announcements

Headline Date
Cleansing Notice 28 June 2023 at 8:45am
Application for quotation of securities - TLX 28 June 2023 at 8:45am
Proposed issue of securities - TLX 21 June 2023 at 6:35pm
Lightpoint Acquisition to Expand Telix Urologic Pipeline 21 June 2023 at 6:35pm
Telix Urology Innovation Showcase 21 June 2023 at 8:45am
Phase II study for indication expansion of TLX250-CDx doses 19 June 2023 at 8:55am
Appendix 3Y Change in Director Interests - C Behrenbruch 2 June 2023 at 8:50am
Notification regarding unquoted securities - TLX 2 June 2023 at 8:50am
Cleansing Notice 2 June 2023 at 8:50am
Application for quotation of securities - TLX 2 June 2023 at 8:40am
Securities Dealing Policy - updated 30 May 2023 at 8:40am
Results of Annual General Meeting 24 May 2023 at 3:05pm
Annual General Meeting - Presentation 24 May 2023 at 11:00am
Annual General Meeting - Chairman and CEO Addresses 24 May 2023 at 10:50am
Notification regarding unquoted securities - TLX 5 May 2023 at 8:25am
Cleansing Notice 2 May 2023 at 8:40am
Application for quotation of securities - TLX 2 May 2023 at 8:40am
Cleansing Notice 1 May 2023 at 9:05am
Application for quotation of securities - TLX 1 May 2023 at 9:05am
ZIRCON Data Presented at AUA Confirms Efficacy in 2cm Masses 1 May 2023 at 8:35am
Proposed issue of securities - TLX 27 April 2023 at 8:40am
Presentation to Accompany AI Development Program Update 27 April 2023 at 8:35am
Telix Accelerates AI Development with Dedicaid Acquisition 27 April 2023 at 8:35am
AGM Notice of Meeting, Proxy Form and Online Guide 21 April 2023 at 8:40am
Q1 2023 Business update to accompany quarterly results 17 April 2023 at 4:15pm
Appendix 4C and Activities Report - March 2023 Quarter 17 April 2023 at 4:15pm
Telix-Grand Pharma Investor Webcast Notification 17 April 2023 at 8:45am
Telix Preclinical Development of Radiolabelled Olaratumab 17 April 2023 at 8:45am
Notification of upcoming quarterly results and investor call 5 April 2023 at 8:40am
Notification of cessation of securities - TLX 5 April 2023 at 8:40am
Cleansing Notice 5 April 2023 at 8:40am
Application for quotation of securities - TLX 5 April 2023 at 8:40am
Illuccix European Marketing Authorisation Application Update 3 April 2023 at 8:50am
Non-Executive Director Leave of Absence 29 March 2023 at 8:50am
Cleansing Notice 21 March 2023 at 8:40am
Application for quotation of securities - TLX 21 March 2023 at 8:40am
App 3Y Change in Director Interests - T Olson 17 March 2023 at 10:15am
FDA approval of expanded indication of Illuccix in the US 16 March 2023 at 11:05am
Date of 2022 AGM 6 March 2023 at 8:40am
Corporate governance statement - Appendix 4G 27 February 2023 at 4:35pm
2022 Full Year Results Presentation 27 February 2023 at 4:35pm
2022 Full Year Results Release 27 February 2023 at 4:30pm
Appendix 4E and 2022 Annual Report 27 February 2023 at 4:30pm
Cleansing Notice 23 February 2023 at 8:40am
Application for quotation of securities - TLX 23 February 2023 at 8:40am
Telix Full Year Results and Investor Conference Call Details 21 February 2023 at 8:25am
Investor briefing on ASCO-GU Zircon Phase III Results 10 February 2023 at 8:50am
Cleansing Notice 2 February 2023 at 9:35am
Application for quotation of securities - TLX 2 February 2023 at 9:35am
Q4 2022 Business update to accompany quarterly results 18 January 2023 at 8:50am
Register to track TLX and receive email alerts.